ArticleCureus2025
A Clinical and Risk Factor Profile of Patients With Tubo-Ovarian Abscesses: A Retrospective Study From Two District Hospitals in the United Kingdom.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk factors for antibiotic treatment failure in tubo-ovarian abscess: a systematic review and meta-analysis.BMC women's health · 2026Pooled it
- A dynamic nomogram for predicting the need for invasive interventions in patients with tubo-ovarian abscess.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA tubo-ovarian abscess (TOA) represents a severe complication of pelvic inflammatory disease requiring prompt recognition and appropriate management. The decision between medical and surgical intervention remains complex, with various factors influencing treatment outcomes. This study aimed to describe the demographic and clinical characteristics of patients presenting with tubo-ovarian masses and identify predictors for surgical intervention while recording treatment outcomes.
methodsThis retrospective observational study analyzed 69 patients with tubo-ovarian masses treated at two district hospitals in the United Kingdom. All patients initially received broad-spectrum intravenous antibiotics, with surgical intervention reserved for those who failed to respond after 72 hours. Demographic characteristics, clinical parameters, laboratory findings, and treatment outcomes were extracted from electronic medical records. Statistical analysis was performed using Statistical Product and Service Solutions (SPSS, version 25.0; IBM SPSS Statistics for Windows, Armonk, NY), with chi-square tests for categorical variables and Mann-Whitney U tests for continuous data.
resultsThe mean age was 42.1±11.1 years, with 39 patients being obese (56.5%). Risk factors included smoking (n=8, 11.6%), intrauterine device (IUD) use (n=12, 17.4%), and diabetes (n=4, 5.8%). Eighteen patients (26.1%) required surgical intervention after failed medical management. Patients requiring surgery had significantly larger abscess size (p=0.036), higher fever prevalence (p=0.045), elevated C-reactive protein (CRP) levels (p=0.004), and longer hospital stays (p<0.001). There were six patients with an early recurrence rate within 45 days (8.7%), with no significant difference between management groups (p=0.647).
conclusionLarger abscess size, presence of fever, and elevated CRP levels are significant predictors of surgical intervention in TOA management. The study population demonstrated an older age profile and high obesity prevalence. These findings provide objective clinical indicators to guide treatment decision-making and optimize patient outcomes in TOA management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.